| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 5.17e-05 | 5 | 46 | 2 | GO:0004749 | |
| GeneOntologyMolecularFunction | spectrin binding | 6.51e-05 | 34 | 46 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 7.74e-05 | 6 | 46 | 2 | GO:0016778 | |
| GeneOntologyMolecularFunction | GDP binding | 9.22e-05 | 103 | 46 | 4 | GO:0019003 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 3.38e-04 | 12 | 46 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | ATP-dependent DNA damage sensor activity | 9.61e-04 | 20 | 46 | 2 | GO:0140664 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 9.61e-04 | 20 | 46 | 2 | GO:0017110 | |
| GeneOntologyMolecularFunction | AMP binding | 1.06e-03 | 21 | 46 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | DNA damage sensor activity | 1.39e-03 | 24 | 46 | 2 | GO:0140612 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.71e-03 | 614 | 46 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.12e-03 | 127 | 46 | 3 | GO:0008094 | |
| GeneOntologyBiologicalProcess | intestinal D-glucose absorption | 3.04e-05 | 4 | 47 | 2 | GO:0001951 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 3.04e-05 | 4 | 47 | 2 | GO:0140973 | |
| GeneOntologyBiologicalProcess | intestinal hexose absorption | 5.06e-05 | 5 | 47 | 2 | GO:0106001 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 7.58e-05 | 6 | 47 | 2 | GO:0006015 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 7.58e-05 | 6 | 47 | 2 | GO:0046391 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 7.58e-05 | 6 | 47 | 2 | GO:0140971 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 1.41e-04 | 8 | 47 | 2 | GO:0140970 | |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 1.81e-04 | 9 | 47 | 2 | GO:2000643 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 1.81e-04 | 9 | 47 | 2 | GO:0140639 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 1.81e-04 | 9 | 47 | 2 | GO:0051715 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 2.26e-04 | 10 | 47 | 2 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 2.26e-04 | 10 | 47 | 2 | GO:1902966 | |
| GeneOntologyBiologicalProcess | cytolysis | 3.31e-04 | 12 | 47 | 2 | GO:0019835 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 4.54e-04 | 14 | 47 | 2 | GO:1905668 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 5.24e-04 | 15 | 47 | 2 | GO:1905666 | |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 5.98e-04 | 16 | 47 | 2 | GO:1902946 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 9.41e-04 | 20 | 47 | 2 | GO:0044406 | |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 9.41e-04 | 20 | 47 | 2 | GO:2000641 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell apical/basal polarity | 1.04e-03 | 21 | 47 | 2 | GO:0045198 | |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 4.93e-05 | 5 | 47 | 2 | GO:0002189 | |
| GeneOntologyCellularComponent | host cell part | 7.38e-05 | 6 | 47 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 7.38e-05 | 6 | 47 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 7.38e-05 | 6 | 47 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | host intracellular region | 7.38e-05 | 6 | 47 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 7.38e-05 | 6 | 47 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 7.38e-05 | 6 | 47 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 7.38e-05 | 6 | 47 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.37e-04 | 8 | 47 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.76e-04 | 9 | 47 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | mismatch repair complex | 2.69e-04 | 11 | 47 | 2 | GO:0032300 | |
| GeneOntologyCellularComponent | uropod | 4.43e-04 | 14 | 47 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | host cellular component | 5.10e-04 | 15 | 47 | 2 | GO:0018995 | |
| GeneOntologyCellularComponent | cell trailing edge | 5.10e-04 | 15 | 47 | 2 | GO:0031254 | |
| GeneOntologyCellularComponent | cell tip | 6.59e-04 | 17 | 47 | 2 | GO:0051286 | |
| GeneOntologyCellularComponent | cell pole | 9.16e-04 | 20 | 47 | 2 | GO:0060187 | |
| GeneOntologyCellularComponent | microvillus membrane | 3.30e-03 | 38 | 47 | 2 | GO:0031528 | |
| MousePheno | decreased circulating cholesterol level | 9.91e-05 | 397 | 39 | 7 | MP:0005179 | |
| MousePheno | decreased cholesterol level | 1.37e-04 | 418 | 39 | 7 | MP:0003983 | |
| MousePheno | decreased sterol level | 1.43e-04 | 421 | 39 | 7 | MP:0012225 | |
| Domain | DUF3523 | 1.70e-05 | 3 | 45 | 2 | PF12037 | |
| Domain | PRPP_SYNTHASE | 1.70e-05 | 3 | 45 | 2 | PS00114 | |
| Domain | DUF3523 | 1.70e-05 | 3 | 45 | 2 | IPR021911 | |
| Domain | PRib_PP_synth_CS | 1.70e-05 | 3 | 45 | 2 | IPR000842 | |
| Domain | ERM_C_dom | 3.40e-05 | 4 | 45 | 2 | IPR011259 | |
| Domain | ERM | 3.40e-05 | 4 | 45 | 2 | IPR011174 | |
| Domain | ERM | 3.40e-05 | 4 | 45 | 2 | PF00769 | |
| Domain | Rib-P_diPkinase | 5.65e-05 | 5 | 45 | 2 | IPR005946 | |
| Domain | Pribosyl_synth | 5.65e-05 | 5 | 45 | 2 | PF14572 | |
| Domain | Pribosyltran_N | 5.65e-05 | 5 | 45 | 2 | IPR029099 | |
| Domain | Pribosyltran_N | 5.65e-05 | 5 | 45 | 2 | PF13793 | |
| Domain | HELP | 8.46e-05 | 6 | 45 | 2 | PF03451 | |
| Domain | HELP | 8.46e-05 | 6 | 45 | 2 | IPR005108 | |
| Domain | Moesin_tail | 1.18e-04 | 7 | 45 | 2 | IPR008954 | |
| Domain | GBP_C | 2.52e-04 | 10 | 45 | 2 | PF02841 | |
| Domain | Guanylate-bd_C | 3.08e-04 | 11 | 45 | 2 | IPR003191 | |
| Domain | GBP | 3.08e-04 | 11 | 45 | 2 | PF02263 | |
| Domain | Pribosyltran | 3.08e-04 | 11 | 45 | 2 | PF00156 | |
| Domain | G_GB1_RHD3_dom | 3.08e-04 | 11 | 45 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 3.08e-04 | 11 | 45 | 2 | IPR015894 | |
| Domain | G_GB1_RHD3 | 3.08e-04 | 11 | 45 | 2 | PS51715 | |
| Domain | - | 3.69e-04 | 12 | 45 | 2 | 3.40.50.2020 | |
| Domain | PRTase-like | 3.69e-04 | 12 | 45 | 2 | IPR029057 | |
| Domain | PRibTrfase_dom | 3.69e-04 | 12 | 45 | 2 | IPR000836 | |
| Domain | VitD_rcpt | 5.07e-04 | 14 | 45 | 2 | IPR000324 | |
| Domain | Apc4_WD40_dom | 1.05e-03 | 20 | 45 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.05e-03 | 20 | 45 | 2 | PF12894 | |
| Domain | PLAT | 1.16e-03 | 21 | 45 | 2 | PF01477 | |
| Domain | Ez/rad/moesin-like | 1.16e-03 | 21 | 45 | 2 | IPR000798 | |
| Domain | PLAT | 1.16e-03 | 21 | 45 | 2 | PS50095 | |
| Domain | PLAT/LH2_dom | 1.16e-03 | 21 | 45 | 2 | IPR001024 | |
| Domain | - | 1.16e-03 | 21 | 45 | 2 | 2.60.60.20 | |
| Domain | FERM_CS | 1.51e-03 | 24 | 45 | 2 | IPR019747 | |
| Domain | FERM_C | 1.78e-03 | 26 | 45 | 2 | PF09380 | |
| Domain | FERM_C | 1.92e-03 | 27 | 45 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 1.92e-03 | 27 | 45 | 2 | IPR018980 | |
| Domain | FYVE | 2.21e-03 | 29 | 45 | 2 | PF01363 | |
| Domain | FYVE | 2.21e-03 | 29 | 45 | 2 | SM00064 | |
| Domain | - | 2.41e-03 | 391 | 45 | 5 | 2.30.29.30 | |
| Domain | FERM_N | 2.86e-03 | 33 | 45 | 2 | IPR018979 | |
| Domain | FERM_N | 2.86e-03 | 33 | 45 | 2 | PF09379 | |
| Domain | Znf_FYVE-rel | 3.03e-03 | 34 | 45 | 2 | IPR017455 | |
| Domain | PH_dom-like | 3.48e-03 | 426 | 45 | 5 | IPR011993 | |
| Domain | Znf_FYVE | 3.78e-03 | 38 | 45 | 2 | IPR000306 | |
| Domain | P-loop_NTPase | 3.90e-03 | 848 | 45 | 7 | IPR027417 | |
| Domain | ZF_FYVE | 4.18e-03 | 40 | 45 | 2 | PS50178 | |
| Domain | FERM_M | 5.49e-03 | 46 | 45 | 2 | PF00373 | |
| Domain | zf-C4 | 5.49e-03 | 46 | 45 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.49e-03 | 46 | 45 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 5.49e-03 | 46 | 45 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 5.49e-03 | 46 | 45 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 5.49e-03 | 46 | 45 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.49e-03 | 46 | 45 | 2 | PS51030 | |
| Domain | - | 5.73e-03 | 47 | 45 | 2 | 1.10.565.10 | |
| Domain | HOLI | 5.97e-03 | 48 | 45 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 5.97e-03 | 48 | 45 | 2 | IPR000536 | |
| Domain | Hormone_recep | 5.97e-03 | 48 | 45 | 2 | PF00104 | |
| Domain | FERM_central | 6.21e-03 | 49 | 45 | 2 | IPR019748 | |
| Domain | FERM_domain | 6.21e-03 | 49 | 45 | 2 | IPR000299 | |
| Domain | - | 6.21e-03 | 49 | 45 | 2 | 1.20.80.10 | |
| Domain | FERM_1 | 6.46e-03 | 50 | 45 | 2 | PS00660 | |
| Domain | FERM_2 | 6.46e-03 | 50 | 45 | 2 | PS00661 | |
| Domain | Band_41_domain | 6.46e-03 | 50 | 45 | 2 | IPR019749 | |
| Domain | B41 | 6.46e-03 | 50 | 45 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 6.46e-03 | 50 | 45 | 2 | IPR014352 | |
| Domain | FERM_3 | 6.46e-03 | 50 | 45 | 2 | PS50057 | |
| Domain | AAA | 6.97e-03 | 52 | 45 | 2 | PF00004 | |
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 7980603 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 8586419 | ||
| Pubmed | Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma. | 1.87e-06 | 2 | 48 | 2 | 27042764 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 36460216 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25299115 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 9213396 | ||
| Pubmed | Dimerization and its role in GMP formation by human guanylate binding proteins. | 1.87e-06 | 2 | 48 | 2 | 20923658 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12111362 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18409517 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 7579708 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23086406 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 2537655 | ||
| Pubmed | Ezrin has properties to self-associate at the plasma membrane. | 1.87e-06 | 2 | 48 | 2 | 7844168 | |
| Pubmed | Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. | 1.87e-06 | 2 | 48 | 2 | 28624994 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20483731 | ||
| Pubmed | Moesin: a member of the protein 4.1-talin-ezrin family of proteins. | 1.87e-06 | 2 | 48 | 2 | 1924289 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8248180 | ||
| Pubmed | PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. | 1.87e-06 | 2 | 48 | 2 | 33493137 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 11726669 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 1429901 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 8479753 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 5.59e-06 | 3 | 48 | 2 | 32098334 | |
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 5.59e-06 | 3 | 48 | 2 | 38636926 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 18261459 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21659656 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19064715 | ||
| Pubmed | Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. | 5.59e-06 | 3 | 48 | 2 | 17046996 | |
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 5.59e-06 | 3 | 48 | 2 | 31843195 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 18295815 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 5.59e-06 | 3 | 48 | 2 | 12360288 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21864676 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 9616160 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 30062052 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 14613898 | ||
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 5.59e-06 | 3 | 48 | 2 | 36639389 | |
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 5.59e-06 | 3 | 48 | 2 | 22132106 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 25816608 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 1314091 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 11706008 | ||
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 5.59e-06 | 3 | 48 | 2 | 28889652 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21278069 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 5.59e-06 | 3 | 48 | 2 | 26555866 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 26416908 | ||
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 5.59e-06 | 3 | 48 | 2 | 23116763 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 38923254 | ||
| Pubmed | [ATAD3, a vital membrane-bound mitochondrial ATPase involved in tumor progression]. | 5.59e-06 | 3 | 48 | 2 | 22192748 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21451358 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 32354743 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 22177047 | ||
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 5.59e-06 | 3 | 48 | 2 | 8706832 | |
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 5.59e-06 | 3 | 48 | 2 | 23703860 | |
| Pubmed | Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma. | 5.59e-06 | 3 | 48 | 2 | 32391636 | |
| Pubmed | ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly. | 5.59e-06 | 3 | 48 | 2 | 34936866 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 16914101 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 32620042 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 9366267 | ||
| Pubmed | [Guanylate-binding protein 2 regulates the maturation of mouse dendritic cells induced by β-glucan]. | 5.59e-06 | 3 | 48 | 2 | 29089068 | |
| Pubmed | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. | 5.59e-06 | 3 | 48 | 2 | 19321616 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 5.59e-06 | 3 | 48 | 2 | 16889625 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 29906485 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 25486435 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 28549128 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 25375035 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20679347 | ||
| Pubmed | The EBP50-moesin interaction involves a binding site regulated by direct masking on the FERM domain. | 5.59e-06 | 3 | 48 | 2 | 15020681 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 22730319 | ||
| Pubmed | Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. | 5.59e-06 | 3 | 48 | 2 | 12385025 | |
| Pubmed | Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? | 5.59e-06 | 3 | 48 | 2 | 25286001 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 29777033 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 15717119 | ||
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 5.59e-06 | 3 | 48 | 2 | 15149851 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17977945 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 15252013 | ||
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 5.59e-06 | 3 | 48 | 2 | 21837648 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 35383115 | ||
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 5.59e-06 | 3 | 48 | 2 | 23248289 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 1715024 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 1962753 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 32160548 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 33552086 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 12734202 | ||
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 5.59e-06 | 3 | 48 | 2 | 21352885 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 5.59e-06 | 3 | 48 | 2 | 19124745 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20950129 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 5.59e-06 | 3 | 48 | 2 | 9862701 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 26175007 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 17237445 | ||
| Pubmed | The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes. | 1.12e-05 | 4 | 48 | 2 | 21148287 | |
| Pubmed | ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models. | 1.12e-05 | 4 | 48 | 2 | 35236834 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 36736924 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 18941185 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9314537 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 15178693 | ||
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 1.12e-05 | 4 | 48 | 2 | 12070130 | |
| Pubmed | CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | 1.12e-05 | 4 | 48 | 2 | 27793041 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 15096511 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 10386861 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 20660156 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 19129194 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 15818415 | ||
| Interaction | EIF5AL1 interactions | 1.89e-05 | 22 | 48 | 3 | int:EIF5AL1 | |
| Interaction | DKK3 interactions | 3.04e-05 | 75 | 48 | 4 | int:DKK3 | |
| Cytoband | 1p22 | 2.01e-04 | 20 | 48 | 2 | 1p22 | |
| Cytoband | 1p22.2 | 3.98e-04 | 28 | 48 | 2 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 4.08e-04 | 137 | 48 | 3 | chr1p22 | |
| Cytoband | 1p36.33 | 2.98e-03 | 77 | 48 | 2 | 1p36.33 | |
| Cytoband | 7q11.23 | 4.68e-03 | 97 | 48 | 2 | 7q11.23 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.37e-03 | 31 | 32 | 2 | 81 | |
| GeneFamily | Nuclear hormone receptors | 3.39e-03 | 49 | 32 | 2 | 71 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.53e-03 | 50 | 32 | 2 | 1293 | |
| GeneFamily | AAA ATPases | 3.95e-03 | 53 | 32 | 2 | 413 | |
| GeneFamily | WD repeat domain containing | 1.09e-02 | 262 | 32 | 3 | 362 | |
| GeneFamily | Actins|Deafness associated genes | 1.70e-02 | 113 | 32 | 2 | 1152 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN | 8.25e-06 | 403 | 48 | 7 | MM1029 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 1.58e-05 | 143 | 47 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 5.15e-05 | 994 | 47 | 10 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 142 | 47 | 4 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-05 | 160 | 47 | 4 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-05 | 167 | 47 | 4 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 169 | 47 | 4 | 2098f15a388d019ed7f1d4c209affd5ca2886dcc | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.09e-05 | 170 | 47 | 4 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 174 | 47 | 4 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.86e-05 | 180 | 47 | 4 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 180 | 47 | 4 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.48e-05 | 187 | 47 | 4 | 43f81863063509337bd56a67010c62fb51109bd5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-05 | 187 | 47 | 4 | ea56cfca919a09db852b7ee5e42323f822962465 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-05 | 188 | 47 | 4 | b6ae707b033a17c75ca81f9194631ead1b63d170 | |
| ToppCell | control-B_memory|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.97e-05 | 192 | 47 | 4 | d6ef271b6c4f9b49323650f3f773abd61c1b13c3 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.97e-05 | 192 | 47 | 4 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.97e-05 | 192 | 47 | 4 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.17e-05 | 194 | 47 | 4 | 6a0cbb9d5c5c4effb02dff654c6c3b184026875c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.17e-05 | 194 | 47 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.27e-05 | 195 | 47 | 4 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 5.38e-05 | 196 | 47 | 4 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.49e-05 | 197 | 47 | 4 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.49e-05 | 197 | 47 | 4 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.49e-05 | 197 | 47 | 4 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 5.60e-05 | 198 | 47 | 4 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | Control-Control-Lymphocyte-B-B_memory|Control / Disease, condition lineage and cell class | 5.71e-05 | 199 | 47 | 4 | 76976d5f79f324a6c488161847c50f207361d6c6 | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.71e-05 | 199 | 47 | 4 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_memory|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.71e-05 | 199 | 47 | 4 | 5bbda86486910d053ca51b9caee487d78f6462cb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 527aae1d9d37a50deefc01fc0c064a53673681bd | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 200 | 47 | 4 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 200 | 47 | 4 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cacng4_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-05 | 76 | 47 | 3 | 4afc8d0e79870c635a89dd8e7ca91ebfe482b4ab | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 87 | 47 | 3 | cc89f4176b70d4eb5b5bf0ff2319b5f1f9e292c0 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 87 | 47 | 3 | 4274e04fa4aca85c2cefd8c5e03d0fa4a4f15536 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 87 | 47 | 3 | 54cbdf80aae3595eaace20c7cbac763282558213 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 87 | 47 | 3 | 8b1a0bd5d6af32afaca19e9c69f86530bbaa309d | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.96e-04 | 123 | 47 | 3 | e0130010aa406d4e9d8f16ad32858c382277eeb2 | |
| ToppCell | Control-Mast_cells-Dendritic_cells|Control / group, cell type (main and fine annotations) | 4.06e-04 | 137 | 47 | 3 | 9906225a2eb1a891e5bfbb00929bc041f325b376 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 141 | 47 | 3 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 141 | 47 | 3 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | TCGA-Adrenal|World / Sample_Type by Project: Shred V9 | 4.79e-04 | 145 | 47 | 3 | 522ad2bc90b8ec326fcbc7b2250b09566efeeca2 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-3|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.89e-04 | 146 | 47 | 3 | e55b4acecf4e363b5afa287c747c2e58c4597f3a | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.19e-04 | 149 | 47 | 3 | 92a8931a51db619fb5f0638d319c02e7838f6559 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 5.50e-04 | 152 | 47 | 3 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.27e-04 | 159 | 47 | 3 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.27e-04 | 159 | 47 | 3 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.27e-04 | 159 | 47 | 3 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-04 | 160 | 47 | 3 | bcd90ef96464bd901b87b94c696de70c113bfd03 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.50e-04 | 161 | 47 | 3 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 161 | 47 | 3 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.50e-04 | 161 | 47 | 3 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.50e-04 | 161 | 47 | 3 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.50e-04 | 161 | 47 | 3 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.50e-04 | 161 | 47 | 3 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.61e-04 | 162 | 47 | 3 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-04 | 162 | 47 | 3 | 3e15b3e97a2ade86d0cb0ab15fccb9a2e2e27dd4 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.61e-04 | 162 | 47 | 3 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-04 | 164 | 47 | 3 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | 67c636a2cc32e56c6186dc7e779cc19af04639d2 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | eae6d440877b292ad18dc4bd02802dda5b2f9c60 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 165 | 47 | 3 | 22293c6b55f44636440cd737efb786ff5de3373d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-04 | 165 | 47 | 3 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.98e-04 | 165 | 47 | 3 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.10e-04 | 166 | 47 | 3 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.22e-04 | 167 | 47 | 3 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 7.35e-04 | 168 | 47 | 3 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.48e-04 | 169 | 47 | 3 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 170 | 47 | 3 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 170 | 47 | 3 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | ILEUM-non-inflamed-(3)_mature_DC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.61e-04 | 170 | 47 | 3 | 60151394460e6f27a42fab434e8b7b2adc78b128 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.61e-04 | 170 | 47 | 3 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 7.74e-04 | 171 | 47 | 3 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 7.74e-04 | 171 | 47 | 3 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.74e-04 | 171 | 47 | 3 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.74e-04 | 171 | 47 | 3 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.74e-04 | 171 | 47 | 3 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.74e-04 | 171 | 47 | 3 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.00e-04 | 173 | 47 | 3 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.00e-04 | 173 | 47 | 3 | e4d9a9a781acc531bc81c3fcee24d637e805c8e1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.00e-04 | 173 | 47 | 3 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | Dendritic_Cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 8.00e-04 | 173 | 47 | 3 | ddb900ef4abeabe2e59db1009efc337e35d301fe | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-04 | 174 | 47 | 3 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.13e-04 | 174 | 47 | 3 | 7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-04 | 174 | 47 | 3 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-04 | 175 | 47 | 3 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.27e-04 | 175 | 47 | 3 | 9941c35601134d88d1b3249c81f8b43a8fc61610 | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 8.27e-04 | 175 | 47 | 3 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.27e-04 | 175 | 47 | 3 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-04 | 176 | 47 | 3 | 71f96cace3f20fbef975037f4deff9b82b0282a1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.41e-04 | 176 | 47 | 3 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.55e-04 | 177 | 47 | 3 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.55e-04 | 177 | 47 | 3 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | 8.55e-04 | 177 | 47 | 3 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 177 | 47 | 3 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 8.55e-04 | 177 | 47 | 3 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.55e-04 | 177 | 47 | 3 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | 5297f7459b40ca780a1983fecc1bb9c035c7677e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.83e-04 | 179 | 47 | 3 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-04 | 179 | 47 | 3 | 4e9e0deabf9b09ffcf30fed6d5eae72ce0ef2f1f | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-04 | 179 | 47 | 3 | f93e81a3fd94adedb24a9db4ac1d53e275bbf8b5 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-04 | 179 | 47 | 3 | 878b15ea62e3405682a538f79f58d74b9cd3f398 | |
| Disease | neuromuscular disease (implicated_via_orthology) | 1.30e-05 | 4 | 44 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | syndrome (implicated_via_orthology) | 3.27e-04 | 18 | 44 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | treatment-resistant hypertension | 5.82e-04 | 109 | 44 | 3 | EFO_1002006 | |
| Disease | response to calcium channel blocker | 3.18e-03 | 56 | 44 | 2 | EFO_0007767 | |
| Disease | Liver Cirrhosis, Experimental | 5.72e-03 | 774 | 44 | 5 | C0023893 | |
| Disease | nicotine dependence | 6.07e-03 | 78 | 44 | 2 | EFO_0003768 | |
| Disease | carpal tunnel syndrome | 7.84e-03 | 89 | 44 | 2 | EFO_0004143 | |
| Disease | eye color | 8.01e-03 | 90 | 44 | 2 | EFO_0003949 | |
| Disease | Degenerative polyarthritis | 8.53e-03 | 93 | 44 | 2 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 8.53e-03 | 93 | 44 | 2 | C0086743 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKKCFRNLFHIRRNK | 156 | Q8N944 | |
| LKAKQRKDPRFCAFV | 526 | Q92888 | |
| KVDAQRRLCFFYNKK | 116 | P43652 | |
| AFRFKRKLPKYLLFT | 566 | P19801 | |
| KRFRCFQAQKLYKRR | 1496 | Q8IZT6 | |
| RRLQKQHFCGRRKKY | 246 | Q8TE60 | |
| SPQERKKRDCYFEFR | 186 | A6NJV1 | |
| PLLDFRRKVNKCYRG | 886 | Q16849 | |
| FNCDCLIPLKRKRKY | 1911 | Q8IVV2 | |
| RKPEKLKTLFCYFRR | 671 | Q86W56 | |
| CRYGRFRKFKSIKAR | 201 | Q8TEB1 | |
| EFQRNIKKKRACFPF | 66 | A8MQ11 | |
| RCRKPKVTQLYKCRF | 251 | O95568 | |
| RKESPLLFKFRAKFY | 71 | P26038 | |
| IRKFFPKKKCFVFDR | 226 | P32455 | |
| RLCIRKFFPKRKCFV | 221 | P32456 | |
| NIKKKRACFPFAFCR | 376 | A4D2B8 | |
| GRKFPFFLRNKEYVC | 1361 | Q8IZD9 | |
| RVIAAFYFPKREKKR | 576 | Q5T197 | |
| CPRRYKPFNARYKLL | 386 | Q8NEA6 | |
| PLTKKLYKRYAFLRC | 891 | Q6ZUT9 | |
| KRRLKLAQFDYGRKC | 326 | Q5T2N8 | |
| RYPCLRKGAKFRKYI | 546 | Q05BV3 | |
| KFPCLKRGAKFRKYV | 546 | Q6ZMW3 | |
| RKENPLQFKFRAKFY | 71 | P15311 | |
| RFLNFFLEKYKRPVC | 321 | Q8IZK6 | |
| CRKKPKARQFFLFND | 46 | Q9H8W4 | |
| DKTQRKRCPYCRFQK | 131 | O00482 | |
| KGFFKRSICNKRVYR | 81 | Q15406 | |
| CRKKAKPRIFFLFND | 46 | Q96S99 | |
| KNLVFRILKKCYRGR | 116 | Q9BQQ7 | |
| QRAARLKTFPCKRFK | 596 | Q9NXH9 | |
| RNIKKKRACFPFAFC | 36 | O95744 | |
| NIKKKRACFPFAFCR | 241 | O95744 | |
| FENGCYLRRQKRFKL | 201 | P55318 | |
| FVFPIYCLCKKQRKR | 521 | Q8TC41 | |
| KRRLKLAQFDYGRKC | 501 | Q5T9A4 | |
| RPYECGEYRKLFKNK | 86 | Q9NXT0 | |
| NKCAYKFQRKRRHKL | 171 | A8MXK1 | |
| CFPYARQDKKDKSRA | 91 | P11908 | |
| RKGKDKFNPRRFCLF | 1331 | Q14997 | |
| KFNPRRFCLFKGIFR | 1336 | Q14997 | |
| LKDKARPFQCRYCVK | 546 | Q96IT1 | |
| CFPYARQDKKDKSRA | 91 | P60891 | |
| EEVYKKLGRKRCPNF | 1326 | O15050 | |
| EKKKGIFRRAYDLFC | 596 | P13866 | |
| FQGKRRKYIINKCRD | 396 | Q7Z4V0 | |
| CIYFDRKRRSDPNFK | 21 | Q15388 | |
| PQDKKEYRLFFRCIR | 66 | Q9UNY4 | |
| PAQCRRRYKFLKDKF | 111 | Q5T230 | |
| RFFRFCVAIKKENYP | 3141 | Q5THJ4 |